Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 3
2006 6
2007 3
2008 3
2009 7
2010 7
2011 5
2012 6
2013 13
2014 17
2015 17
2016 16
2017 9
2018 11
2019 14
2020 21
2021 22
2022 23
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging.
van Dorth D, Jiang FY, Schmitz-Abecassis B, Croese RJI, Taphoorn MJB, Smits M, Koekkoek JAF, Dirven L, de Bresser J, van Osch MJP. van Dorth D, et al. Among authors: taphoorn mjb. NMR Biomed. 2024 Apr 23:e5166. doi: 10.1002/nbm.5166. Online ahead of print. NMR Biomed. 2024. PMID: 38654579
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.
Millward CP, Keshwara SM, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Islim AI, Javadpour M, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Among authors: taphoorn mjb. Neurooncol Adv. 2024 Mar 2;6(1):vdae030. doi: 10.1093/noajnl/vdae030. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596717 Free PMC article.
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review.
Millward CP, Islim AI, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Among authors: taphoorn mjb. Neurooncol Adv. 2024 Mar 19;6(1):vdae042. doi: 10.1093/noajnl/vdae042. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596715 Free PMC article.
RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
Kapteijn MY, Lanting VR, Kaptein FHJ, Guman NAM, Laghmani EH, Kuipers TB, Mei H, Goeman JJ, Mulder FI, van Duinen SG, Taphoorn MJB, Dirven L, Broekman MLD, van Es N, Klok FA, Koekkoek JAF, Versteeg HH, Buijs JT. Kapteijn MY, et al. Among authors: taphoorn mjb. Thromb Res. 2023 Dec;232:27-34. doi: 10.1016/j.thromres.2023.10.018. Epub 2023 Oct 29. Thromb Res. 2023. PMID: 37918288 Free article.
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival.
Schmitz-Abecassis B, Dirven L, Jiang J, Keller JA, Croese RJI, van Dorth D, Ghaznawi R, Kant IMJ, Taphoorn MJB, van Osch MJP, Koekkoek JAF, de Bresser J. Schmitz-Abecassis B, et al. Among authors: taphoorn mjb. Neurooncol Adv. 2023 Oct 12;5(1):vdad133. doi: 10.1093/noajnl/vdad133. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37908765 Free PMC article.
An Impact Factor for Neuro-Oncology Practice.
Taphoorn MJB. Taphoorn MJB. Neurooncol Pract. 2023 Jul 13;10(4):317. doi: 10.1093/nop/npad036. eCollection 2023 Aug. Neurooncol Pract. 2023. PMID: 37457225 Free article. No abstract available.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, Taal W, Clement PM, Idbaih A, de Vos FYF, Klein M, Wick W, Mulholland PJ, Lewis J, Golfinopoulos V, Ghislain I, Bottomley A, van den Bent MJ; EORTC Brain Tumor Group. Reijneveld JC, et al. Among authors: taphoorn mjb. Eur J Cancer. 2023 Sep;190:112946. doi: 10.1016/j.ejca.2023.112946. Epub 2023 Jun 19. Eur J Cancer. 2023. PMID: 37453240 Free article. Clinical Trial.
205 results